Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid

Objectives: Clinical experience with linezolid in the treatment of infective endocarditis either atone or in combination with other agents is limited. We describe our experience in the treatment of two patients with IE due to multi-resistant Gram-positive bacteria. Methods: One patient with MRSE and one with VRE endocarditis were treated with regimens containing Linezolid. The killing kinetics of linezolid in combination with gentamicin or vancomycin against isolates of Staphylococcus epidermidis and Enterococcus faecalis were analysed in vitro. Results: Clinical response and eradication of bacteraemia was achieved with linezolid therapy in both patients. Time-kill curve studies showed that linezolid was bacteriostatic against the MRSE and VRE isolates used. Combination with gentamicin or vancomycin did not produce synergy or antagonism but at best only marginal additive effect. Conclusions: Although bacteriostatic, linezolid provides an important therapeutic option in IE due to multi-resistant Gram-positive pathogens. It challenges the conventional wisdom that bactericidal synergy is required for the effective treatment of most cases of IE due to Gram-positive organisms. (C) 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.